BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30111638)

  • 1. Measuring Disease Activity and Damage with Validated Metrics: A Systematic Review on Mortality and Damage in Systemic Lupus Erythematosus.
    Keeling SO; Vandermeer B; Medina J; Chatterley T; Nevskaya T; Pope J; Alaburubalnabi Z; Bissonauth A; Touma Z
    J Rheumatol; 2018 Oct; 45(10):1448-1461. PubMed ID: 30111638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus.
    Keeling SO; Alabdurubalnabi Z; Avina-Zubieta A; Barr S; Bergeron L; Bernatsky S; Bourre-Tessier J; Clarke A; Baril-Dionne A; Dutz J; Ensworth S; Fifi-Mah A; Fortin PR; Gladman DD; Haaland D; Hanly JG; Hiraki LT; Hussein S; Legault K; Levy D; Lim L; Matsos M; McDonald EG; Medina-Rosas J; Pardo Pardi J; Peschken C; Pineau C; Pope J; Rader T; Reynolds J; Silverman E; Tselios K; Suitner M; Urowitz M; Touma Z; Vinet E; Santesso N
    J Rheumatol; 2018 Oct; 45(10):1426-1439. PubMed ID: 30173152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practice Variations in the Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus in Canada.
    Keeling SO; Bissonauth A; Bernatsky S; Vandermeer B; Fortin PR; Gladman DD; Peschken C; Urowitz MB
    J Rheumatol; 2018 Oct; 45(10):1440-1447. PubMed ID: 30068762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care.
    Castrejón I; Tani C; Jolly M; Huang A; Mosca M
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-85-95. PubMed ID: 25365095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in Clinical Features and Mortality between Childhood-onset and Adult-onset Systemic Lupus Erythematosus: A Prospective Single-center Study.
    Joo YB; Park SY; Won S; Bae SC
    J Rheumatol; 2016 Aug; 43(8):1490-7. PubMed ID: 27252431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late-onset systemic lupus erythematosus: Is it "mild lupus"?
    Sohn IW; Joo YB; Won S; Bae SC
    Lupus; 2018 Feb; 27(2):235-242. PubMed ID: 28650278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features, damage accrual, and survival in patients with familial systemic lupus erythematosus: data from a multi-ethnic, multinational Latin American lupus cohort.
    Quintana R; Pons-Estel GJ; Roberts K; Sacnún M; Serrano R; Nieto R; Conti S; Gervasoni V; Catoggio LJ; Soriano ER; Scolnik M; García MA; Alvarellos A; Saurit V; Berbotto GA; Sato EI; Costallat LTL; Neto EFB; Bonfa E; Xavier RM; de Oliveira E Silva Montandon AC; Molina-Restrepo JF; Iglesias-Gamarra A; Guibert-Toledano M; Reyes-Llerena GA; Massardo L; Neira OJ; Cardiel MH; Barile-Fabris LA; Amigo MC; Silveira LH; Torre IG; Acevedo-Vásquez EM; Ugarte-Gil MF; Alfaro-Lozano JL; Segami MI; Chacón-Díaz R; Esteva-Spinetti MH; Gomez-Puerta JA; Alarcón GS; Pons-Estel BA
    Lupus; 2020 Aug; 29(9):1140-1145. PubMed ID: 32605527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort.
    Watson L; Leone V; Pilkington C; Tullus K; Rangaraj S; McDonagh JE; Gardner-Medwin J; Wilkinson N; Riley P; Tizard J; Armon K; Sinha MD; Ioannou Y; Archer N; Bailey K; Davidson J; Baildam EM; Cleary G; McCann LJ; Beresford MW;
    Arthritis Rheum; 2012 Jul; 64(7):2356-65. PubMed ID: 22294381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus.
    Nived O; Jönsen A; Bengtsson AA; Bengtsson C; Sturfelt G
    J Rheumatol; 2002 Jul; 29(7):1398-400. PubMed ID: 12136895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-cultural validation of a disease-specific patient-reported outcome measure for systemic lupus erythematosus in Canada.
    Bourré-Tessier J; Clarke AE; Mikolaitis-Preuss RA; Kosinski M; Bernatsky S; Block JA; Jolly M
    J Rheumatol; 2013 Aug; 40(8):1327-33. PubMed ID: 23772082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment pathways in an inception lupus cohort over the first three years.
    Hanly JG; Sayani A; Doucette S; Iczkovitz S; Terres JAR
    Lupus; 2017 Feb; 26(2):119-124. PubMed ID: 27365369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Organ Damage Progression and Effect on Health-related Quality of Life in Systemic Lupus Erythematosus.
    Legge A; Doucette S; Hanly JG
    J Rheumatol; 2016 Jun; 43(6):1050-6. PubMed ID: 27084911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Damage accumulation in systemic lupus erythematosus and its relation to disease activity and mortality.
    Becker-Merok A; Nossent HC
    J Rheumatol; 2006 Aug; 33(8):1570-7. PubMed ID: 16845708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chinese Systemic Lupus Erythematosus Treatment and Research Group (CSTAR) Registry XI: gender impact on long-term outcomes.
    Zhang S; Ye Z; Li C; Li Z; Li X; Wu L; Liu S; Zuo X; Zhu P; Wang Z; Wang Y; Wang Z; Zhao J; Wang Q; Tian X; Li M; Zeng X
    Lupus; 2019 Apr; 28(5):635-641. PubMed ID: 30939980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the Charlson comorbidity index with mortality in systemic lupus erythematosus.
    Jönsen A; Clarke AE; Joseph L; Belisle P; Bernatsky S; Nived O; Bengtsson AA; Sturfelt G; Pineau CA
    Arthritis Care Res (Hoboken); 2011 Sep; 63(9):1233-7. PubMed ID: 21618451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index with measures of disease activity and health status in patients with systemic lupus erythematosus.
    Stoll T; Stucki G; Malik J; Pyke S; Isenberg DA
    J Rheumatol; 1997 Feb; 24(2):309-13. PubMed ID: 9034988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of follow-up visits on disease outcome in Chinese systemic lupus erythematosus.
    Ma H; Dong J; Wang L; Zhao L; Pan L
    Clin Rheumatol; 2018 Jan; 37(1):101-105. PubMed ID: 28776301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking and Its Association With Morbidity in Systemic Lupus Erythematosus Evaluated by the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index: Preliminary Data and Systematic Review.
    Montes RA; Mocarzel LO; Lanzieri PG; Lopes LM; Carvalho A; Almeida JR
    Arthritis Rheumatol; 2016 Feb; 68(2):441-8. PubMed ID: 26359794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage.
    Brunner HI; Silverman ED; To T; Bombardier C; Feldman BM
    Arthritis Rheum; 2002 Feb; 46(2):436-44. PubMed ID: 11840446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal clinically important differences of disease activity indices in childhood-onset systemic lupus erythematosus.
    Brunner HI; Higgins GC; Klein-Gitelman MS; Lapidus SK; Olson JC; Onel K; Punaro M; Ying J; Giannini EH
    Arthritis Care Res (Hoboken); 2010 Jul; 62(7):950-9. PubMed ID: 20589695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.